Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients-Reference-Cited by-同舟云学术

Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients

Published:2008-06-21 Issue:10 Volume:9 Page:1629-1639
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Nakou E,Filippatos TD,Liberopoulos EN,Tselepis AD,Kiortsis DN,Mikhailidis DP,Elisaf MS

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.9.10.1629

Reference51 articles.

1. International Day for the Evaluation of Abdominal Obesity (IDEA)

2. Effect of sibutramine on weight maintenance after weight loss: a randomised trial

3. Effect of Weight Loss on Blood Pressure, Arterial Compliance, and Insulin Resistance in Normotensive Obese Subjects

4. Blood Pressure and Pulse Pressure during Long-Term Weight Loss in the Obese: The Swedish Obese Subjects (SOS) Intervention Study

5. Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations for Severe Hypertriglyceridemia Treatment, are there New Strategies?;Current Vascular Pharmacology;2014-07-31

2. Safety of antiobesity drugs;Therapeutic Advances in Drug Safety;2013-05-23

3. Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile;Nutrition, Metabolism and Cardiovascular Diseases;2013-04

4. Drug Treatment for Obesity in the Post-Sibutramine Era;Drug Safety;2011-08

5. Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia;Expert Opinion on Pharmacotherapy;2011-07-08